This content is machine translated MINOCA Not harmless, but often overlooked: Myocardial infarction without coronary vessel obstruction In cardiology, MINOCA defined a new infarct subtype that is still frequently overlooked in clinical practice. However, the prognostic relevance cannot be dismissed.
View Post 1 min This content is machine translated Heart attack risk The microbiome can beat on the heart Every year, around 280,000 people suffer a heart attack in Germany alone. In addition to high blood pressure, high blood cholesterol levels, smoking, obesity and lack of exercise are the…
View Post 2 min This content is machine translated Coronary heart disease (CHD) Blood pressure reduction – how deep is deep enough? Coronary artery disease correlates closely with arterial hypertension. Therefore, to prevent damage to the left ventricular myocardium or the risk of stroke, blood pressure should be lowered. Only how far?
View Post 8 min This content is machine translated Left ventricular assist device (LVAD) Heart failure: who benefits from mechanical circulatory support A number of treatment options are available today for patients with chronic heart failure. It is not always easy to make the right choice.
View Post 2 min This content is machine translated Annual Meeting of the Swiss Brain Stroke Society, Zurich PCSK9 inhibitors keep acute coronary syndrome at bay It is well known that low LDL cholesterol reduces the risk of cardiovascular disease. But in practice, this is often easier said than done. Are PCSK9 inhibitors the solution?
View Post 13 min This content is machine translated Type 2 diabetes Focus on heart & kidney: therapy choice in patients with limiting factors Classes of drugs with different mechanisms of action are available for the treatment of type 2 diabetes. However, the presence of renal or cardiac insufficiency, cardiovascular disease, or insulin deficiency…
View Post 8 min This content is machine translated Accidental hypothermia “Nobody is dead until warm and dead” Although hypothermia is a rather rare phenomenon, mortality is still relatively high today. Rapid recognition of hypothermia and adequate treatment make the difference between life and death.
View Post 8 min This content is machine translated Therapy refractory heart failure Mechanical circuit support in theory and practice Patients with refractory cardiovascular failure are dependent on mechanical circulatory support. When do short-term systems such as ECMO or Impella come into play? In which cases is long-term support provided?
View Post 10 min This content is machine translated Carotid stenosis Overview of current treatment options Today, the treatment of carotid stenosis is interdisciplinary and individualized. Findings from earlier studies cannot be readily applied to today’s situation because medical advances have changed the boundary conditions. What…
View Post 4 min This content is machine translated AHA Scientific Sessions 2018 Dapagliflozin reduces heart failure hospitalization rate Diabetes is associated with an increased cardiovascular risk, which should be taken into account therapeutically. In 2015, the EMPA-REG OUTCOME study demonstrated positive cardiovascular effects of the SGLT-2 inhibitor empagliflozin.…
View Post 9 min This content is machine translated vvECMO and vaECLS Bridge-to-decision in respiratory failure and cardiogenic shock. Studies such as CESAR or SHOCK II, but also the further development of pumps, oxygenators and perfusion tubing have contributed to the fact that therapy with ECMO and ECLS has…
